USD 13.09
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 109.79 Million USD | 160.3% |
2022 | 42.18 Million USD | 464.23% |
2021 | 7.47 Million USD | 85.51% |
2020 | 4.03 Million USD | 5497.22% |
2019 | 72 Thousand USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 109.91 Million USD | 0.06% |
2024 Q1 | 109.84 Million USD | 0.04% |
2023 Q1 | 42.2 Million USD | 0.05% |
2023 FY | 109.79 Million USD | 160.3% |
2023 Q4 | 109.79 Million USD | 159.65% |
2023 Q3 | 42.28 Million USD | 0.07% |
2023 Q2 | 42.25 Million USD | 0.13% |
2022 Q3 | 42.49 Million USD | -0.06% |
2022 FY | 42.18 Million USD | 464.23% |
2022 Q2 | 42.51 Million USD | 0.11% |
2022 Q1 | 42.47 Million USD | 468.1% |
2022 Q4 | 42.18 Million USD | -0.73% |
2021 Q2 | 22.11 Million USD | 0.0% |
2021 FY | 7.47 Million USD | 85.51% |
2021 Q1 | - USD | -100.0% |
2021 Q4 | 7.47 Million USD | -67.98% |
2021 Q3 | 23.35 Million USD | 5.57% |
2020 FY | 4.03 Million USD | 5497.22% |
2020 Q1 | - USD | 0.0% |
2020 Q4 | 4.03 Million USD | 0.0% |
2019 FY | 72 Thousand USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Abbott Laboratories | 13.59 Billion USD | 99.193% |
Allurion Technologies Inc. | 2.3 Million USD | -4661.448% |
Artivion, Inc. | 305.53 Million USD | 64.063% |
Avanos Medical, Inc. | 159.4 Million USD | 31.117% |
Butterfly Network, Inc. | 22.83 Million USD | -380.836% |
Butterfly Network, Inc. | 22.83 Million USD | -380.836% |
Bio-Rad Laboratories, Inc. | 1.18 Billion USD | 90.769% |
Boston Scientific Corporation | 8.96 Billion USD | 98.775% |
CONMED Corporation | 971.48 Million USD | 88.698% |
Edwards Lifesciences Corporation | 670 Million USD | 83.612% |
Glaukos Corporation | 383.73 Million USD | 71.387% |
Globus Medical, Inc. | 417.4 Million USD | 73.695% |
Inspire Medical Systems, Inc. | 24.84 Million USD | -341.918% |
Integer Holdings Corporation | 959.92 Million USD | 88.562% |
Medtronic plc | 23.87 Billion USD | 99.54% |
Myomo, Inc. | 115.16 Thousand USD | -95244.738% |
Nevro Corp. | 211.47 Million USD | 48.078% |
Owlet, Inc. | 22 Thousand USD | -498986.364% |
Penumbra, Inc. | 220.9 Million USD | 50.297% |
Vicarious Surgical Inc. | 13.78 Million USD | -696.511% |
Smith & Nephew plc | 2.17 Billion USD | 94.952% |
STERIS plc | 3.12 Billion USD | 96.481% |
Stryker Corporation | 10.9 Billion USD | 98.993% |
Vapotherm, Inc. | 109.97 Million USD | 0.163% |
Zimmer Biomet Holdings, Inc. | 4.86 Billion USD | 97.744% |